Are you in routine eyecare practice and interested in undertaking a practice-based part time (over up to 6 years) PhD focused on understanding the changes in patients tear film and ocular surface over time? A full PhD fee waiver will be awarded to successful candidates and the research can be conducted largely remotely.
Studies demonstrate that about one in three adults [1-3] and one in five children [4] meet the diagnostic criteria for dry eye disease, hence it is commonly encountered in routine primary eye care. The recent TFOS DEWS III report has updated the definition, diagnostic algorithm, identification of pathophysiological drivers and evidence-based management of dry eye disease [5-7]. However, there is scarce literature on changes in the tear film and ocular surface over time in those who are untreated or those who adopt a treatment [8, 9]. The effect of compliance in the latter group also warrants investigation.
This project will:
• Review past longitudinal studies relating to the tear film and ocular surface to identify areas of particular interest
• Establish a group of adults and / or children who will attend their practice at 6 monthly intervals for any symptoms to be reported and their ocular surface to be examined
• Examine treatment compliance and yearly variations in symptomology using the MyDryEye app
Please note: The practice will need to cover standard clinical consumables such as fluorescein and lissamine green dyes and would ideally have an instrument that can objectively quantify tear film metrics such as non-invasive breakup time.
References
[1] Cai Y, Wei J, Zhou J, Zou W. Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis. Ophthalmic Research 2022;65(6):647-58. https://doi.org/10.1159/000525696.
[2] García-Marqués JV, Talens-Estarelles C, García-Lázaro S, Wolffsohn JS, Cerviño A. Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population. Contact Lens and Anterior Eye 2022;45(5):101539. https://doi.org/https://doi.org/10.1016/j.clae.2021.101539.
[3] Vidal-Rohr M, Craig JP, Davies LN, Wolffsohn JS. The epidemiology of dry eye disease in the UK: The Aston dry eye study. Contact Lens Anterior Eye 2023;46(3):101837. https://doi.org/10.1016/j.clae.2023.101837.
[4] Stapleton F, Velez FG, Lau C, Wolffsohn JS. Dry eye disease in the young: A narrative review. The ocular surface 2024;31:11-20. https://doi.org/10.1016/j.jtos.2023.12.001.
[5] Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S, et al. TFOS DEWS III: Management and Therapy. American journal of ophthalmology 2025;279:289-386. https://doi.org/10.1016/j.ajo.2025.05.039.
[6] Stapleton F, Argüeso P, Asbell P, Azar D, Bosworth C, Chen W, et al. TFOS DEWS III: Digest. American journal of ophthalmology 2025;279:451-553. https://doi.org/10.1016/j.ajo.2025.05.040.
[7] Wolffsohn JS, Benítez-Del-Castillo JM, Loya-Garcia D, Inomata T, Iyer G, Liang L, et al. TFOS DEWS III: Diagnostic Methodology. American journal of ophthalmology 2025;279:387-450. https://doi.org/10.1016/j.ajo.2025.05.033.
[8] Amparo F, Dana R. Web-based longitudinal remote assessment of dry eye symptoms. The ocular surface 2018;16(2):249-53. https://doi.org/10.1016/j.jtos.2018.01.002.
[9] Zhou Y, Murrough J, Yu Y, Roy N, Sayegh R, Asbell P, et al. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study. JAMA Ophthalmology 2022;140(4):392-9. https://doi.org/10.1001/jamaophthalmol.2022.0140